{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-138936","form_type":"8-K","ticker":"TEVA","cik":"0000818686","company_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","filed_at":"2024-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.069291+00:00","generated_at":"2026-06-01T23:54:10.060007+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Teva appoints Matthew Shields as EVP Global Operations; Eric Drapé departs after 11 years","bullets":["Matthew Shields becomes EVP Global Operations effective June 3, 2024, based in Parsippany, NJ.","Shields previously SVP Manufacturing at Merck Animal Health; prior roles at Sanofi and Amgen.","Initial base salary of $825,000 with 100% target annual cash incentive, equity awards, and $200,000 sign-on cash.","Eric Drapé leaves Teva after 11 years, including over 4 years as EVP Global Operations.","Shields reports directly to CEO Richard Francis as part of the Pivot to Growth strategy."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-138936","json":"https://secwatch.observer/filing/0001193125-24-138936.json","markdown":"https://secwatch.observer/filing/0001193125-24-138936.md","text":"https://secwatch.observer/filing/0001193125-24-138936.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818686/000119312524138936/0001193125-24-138936-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818686/000119312524138936/d820660d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T23:54:10.060007+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"822d1a6f77","claim":"Eric Drapé departed as Executive Vice President, Global Operations at TEVA PHARMACEUTICAL INDUSTRIES LTD.","evidence_excerpt":"Mr. Eric Drapé, Executive Vice President, Global Operations, will be leaving Teva Pharmaceutical Industries Ltd.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/818686/000119312524138936/0001193125-24-138936-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will be leaving"},{"label":"Role","value":"Executive Vice President, Global Operations"}],"fact_type":"executive_change"},{"claim_id":"c36adf54ef","claim":"Matthew Shields was appointed as Executive Vice President, Global Operations at TEVA PHARMACEUTICAL INDUSTRIES LTD.","evidence_excerpt":"Mr. Matthew Shields has been appointed as Executive Vice President, Global Operations of Teva and a member of Teva Executive Management, effective June 3, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/818686/000119312524138936/0001193125-24-138936-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President, Global Operations"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}